Preventive Effect of Dapsone on Renal Scarring following Mannose-Sensitive Piliated Bacterial Infection

Renal scarring has been thought to occur in the later stages of chronic pyelonephritis. We previously reported that mannose-sensitive (MS) piliated bacteria promoted renal scarring, which was prevented by antioxidants. The preventive effect of diaphenylsulfone (dapsone), which has a scavenging activity on active oxygen species, on renal scarring was examined. Female Sprague-Dawley rats were inoculated with clinical isolates of Serratia marcescens which had both MS and mannose-resistant pili or with recombinant strains which had MS pili on their surface; they were then administered 20 mg/kg of dapsone or not. Dapsone significantly suppressed scarring following infection of the kidney. The bacterial counts in the kidneys were not different in dapsone-treated and nontreated rats. We conclude that dapsone is effective in preventing renal scarring, and it is suggested that the clinical use of this drug may prevent renal scar formation following pyelonephritis.

[1]  R. Gilmour,et al.  High grade vesicoureteral reflux: analysis of observational therapy. , 1990, The Journal of urology.

[2]  Y. Mizunoe,et al.  Suitability of colchicine and superoxide dismutase for the suppression of renal scarring following an infection with bacteria showing mannose-sensitive pili. , 1990, Nephron.

[3]  J. Roberts,et al.  Treatment of experimental pyelonephritis in the monkey. , 1990, The Journal of urology.

[4]  P. Meylan,et al.  Relationship between neutrophil-mediated oxidative injury during acute experimental pyelonephritis and chronic renal scarring , 1989, Infection and immunity.

[5]  R. White,et al.  Vesicoureteric reflux and renal scarring. , 1989, Archives of disease in childhood.

[6]  Y. Nakabeppu,et al.  Cloning and sequence of the gene encoding the major structural component of mannose-resistant fimbriae of Serratia marcescens , 1988, Journal of bacteriology.

[7]  M. Majd,et al.  A nonsurgical approach to the management of primary vesicoureteral reflux. , 1987, The Journal of urology.

[8]  Y. Miyachi,et al.  Dissociation of the inhibitory effect of dapsone on the generation of oxygen intermediates--in comparison with that of colchicine and various scavengers. , 1984, Biochemical pharmacology.

[9]  M. Maeda,et al.  [Dissociation of the inhibitory effect of dapsone on the generation of oxygen intermediates. In comparison with the effect of Colchicine and various other catalytic scavengers]. , 1982, Arerugi = [Allergy].

[10]  J. Billé,et al.  Protection against chronic pyelonephritis in rats by suppression of acute suppuration: effect of colchicine and neutropenia. , 1982, The Journal of infectious diseases.

[11]  I. Slotki,et al.  Prevention of scarring in experimental pyelonephritis in the rat by early antibiotic therapy. , 1982, Nephron.

[12]  I. Sneddon,et al.  Subcorneal pustular dermatosis , 1979, The British journal of dermatology.

[13]  C. Dahlgren,et al.  The inhibition of polymorphonuclear leukocyte cytotoxicity by dapsone. A possible mechanism in the treatment of dermatitis herpetiformis. , 1978, The Journal of clinical investigation.

[14]  R. White,et al.  Renal scarring and vesicoureteric reflux. , 1978, Archives of disease in childhood.

[15]  J M Lyons,et al.  Prevention of chronic experimental pyelonephritis by suppression of acute suppuration. , 1978, The Journal of clinical investigation.

[16]  David Bruce Lewis,et al.  Anti‐inflammatory actions of dapsone and its related biochemistry , 1976, The Journal of pharmacy and pharmacology.

[17]  N. Prescod,et al.  Vesico-ureteric reflux and renal scarring. , 1975, Kidney international. Supplement.

[18]  M. Ward,et al.  Dapsone in crohn's disease , 1975, The Lancet.

[19]  A. L. Macmillan,et al.  Generalized pustular psoriasis treated with Dapsone , 1973, The British journal of dermatology.

[20]  R. Winkelmann,et al.  CUTANEOUS AND VISCERAL SYNDROMES OF NECROTIZING OR “ALLERGIC” ANGIITIS: A STUDY OF 38 CASES , 1964, Medicine.

[21]  R. Winkelmann,et al.  Dermatitis herpetiformis with acantholysis or pemphigus with response to sulfonamides: report of two cases. , 1960, Archives of dermatology.